Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Lumora Names Reid as Chairman; Evogen Promotes St. Clair

Premium

Lumora has appointed Jim Reid as chairman.

Reid has spent more than 35 years in the bioscience and diagnostic industries in a number of positions at companies such as Organon, Bioscot, Roche, Chiron, and Trinity Biotech. He also holds a number of non-executive director positions, including with Sistemic, Ocutec, and BioFilm.


Evogen has named Richard St. Clair as vice president of commercialization.

St. Clair previously served as director of marketing and business development at Evogen. He will be responsible commercializing Evogen and Sceptor products for the healthcare, biodefense, and industrial markets.

St. Clair holds a BA in human biology from the University of Kansas and an MBA from Webster University.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.